Sermorelin's FDA Journey: Approved, Discontinued, and Compounded Sermorelin acetate (Geref) was FDA-approved in 1997 for pediatric GHD 1 and in 1990 for diagnostic use.26 The manufacturer discontinued Geref in 2008 due to "manufacturing difficulties," not safety or efficacy concerns.12 In 2013, the FDA confirmed it wasn't withdrawn for safety/effectiveness, allowing for potential generic approvals.12 Currently, Sermorelin is primarily available as a compounded medication 3, which is permitted but not individually FDA-approved like mass-produced drugs.22 5.2
Stimulates the Body's Production of Testosterone Hormone, Aiding in Muscle Building and Enhancing Fertility in Men
If you experience any pain or discomfort, stop immediately and take rest
Gut microbiota regulates postprandial GLP-1 response via ileal bile acid-TGR5 signaling
it also increases the risk of serious health issues
This product and all related information have not been evaluated by the U.S